Physical Activity Training for Wheelchair Users
(WATCH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help wheelchair users improve heart and metabolism health by identifying the best exercise methods. Participants will either join a 14-week supervised exercise program, known as Intensity-controlled Physical Activity Training (IPAT), or receive resources to exercise independently at an accessible gym, referred to as Education and Access (EA). It suits wheelchair users who have been exercising less than an hour of moderate activity per week and can move at least one arm independently. As an unphased trial, this study provides a unique opportunity for participants to explore effective exercise strategies tailored to their needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this physical activity training is safe for wheelchair users?
Research has shown that intensity-controlled physical activity training (IPAT) is generally manageable for wheelchair users. In past studies, participants completed the exercise program with only minor side effects, indicating it doesn't cause significant harm or discomfort.
Another study on high-intensity interval training (HIIT) for wheelchair users found the exercises safe. Participants handled the physical demands without major problems.
Overall, these findings suggest that structured physical activity training like IPAT is safe for wheelchair users. It is designed to be effective without causing significant negative effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it offers new ways to help wheelchair users stay active. The Intensity-controlled Physical Activity Training (IPAT) is distinctive because it combines personalized, supervised workouts with access to an accessible gym, making it more structured than typical self-guided exercise programs. Meanwhile, the Education and Access (EA) component empowers individuals by providing them with the knowledge and resources to develop their own exercise routines. Together, these approaches aim to enhance physical activity levels and overall health for wheelchair users, which could lead to improved quality of life and greater independence.
What evidence suggests that this trial's treatments could be effective for improving cardiometabolic health in wheelchair users?
Research shows that intensity-controlled physical activity training (IPAT), which participants in this trial may receive, can benefit people who use wheelchairs. Studies have found that more intense exercise can improve heart health and help manage weight and blood sugar levels. Many wheelchair users often lead less active lifestyles, increasing their risk of heart disease and other health issues. Structured and supervised exercise can reduce these risks, promoting more active habits and better overall health. The IPAT approach aims to make exercise both effective and manageable for people with physical disabilities. Another group in this trial will receive education and access to a community-based accessible gym to independently complete a 14-week physical activity program.12367
Who Is on the Research Team?
Kerri A Morgan, PhD
Principal Investigator
Washington University School of Medicine
Are You a Good Fit for This Trial?
This trial is for adults over 18 who use wheelchairs due to physical disabilities, can consent, speak English, and are able to move at least one arm. Participants should live in the community and not be very active currently—doing less than an hour of moderate exercise a week.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 14-week physical activity intervention, either intensity-controlled or independent, to improve cardiometabolic health
Follow-up
Participants are monitored for changes in cardiometabolic health outcomes, including VO2max, body composition, and metabolic blood chemistries
What Are the Treatments Tested in This Trial?
Interventions
- Education and Access (EA)
- Intensity-controlled physical activity training (IPAT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor